Chair, Department of Psychiatry and Behavioral Sciences
Oklahoma State University
Oklahoma State University
tulsa, Oklahoma
Dr. Jason Beaman is a leading expert in the opioid epidemic and has served as one of Oklahoma’s leading experts in litigation against pharmaceutical companies, including Johnson and Johnson. Dr. Beaman’s research focuses on the origins of the opioid epidemic and the epidemiology of substance use. His research includes serving as the primary investigator of the NIJ funded Oklahoma Methamphetamine Data Initiative.
Dr. Jason Beaman graduated medical school from Oklahoma State University Center for Health Sciences. He then completed two simultaneous residencies in Psychiatry and Family Medicine.
After residency, Dr. Beaman completed a fellowship in Forensic Psychiatry at Case Western Reserve University in Cleveland, Ohio. He holds board certifications in Family Medicine, Psychiatry, Forensic Psychiatry, and Addiction Medicine. After Fellowship, Dr. Beaman completed a Master’s Degree in Pharmacology with an emphasis in Forensics at the University of Florida. He also obtained a Master’s Degree in Pharmacology with an emphasis in Forensics at the University of Florida in addition to a Master’s Degree in Public Health from Johns Hopkins University.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Tuesday, April 19, 2022
2:15 PM – 3:30 PM ET